Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 10

1.

Effects of airborne toxicants on pulmonary function and mitochondrial DNA damage in rodent lungs.

Rumsey WL, Bolognese B, Davis AB, Flamberg PL, Foley JP, Katchur SR, Kotzer CJ, Osborn RR, Podolin PL.

Mutagenesis. 2017 May 1;32(3):343-353. doi: 10.1093/mutage/gew063.

PMID:
27993944
2.

Pharmacological characterization of GSK573719 (umeclidinium): a novel, long-acting, inhaled antagonist of the muscarinic cholinergic receptors for treatment of pulmonary diseases.

Salmon M, Luttmann MA, Foley JJ, Buckley PT, Schmidt DB, Burman M, Webb EF, DeHaas CJ, Kotzer CJ, Barrett VJ, Slack RJ, Sarau HM, Palovich MR, Lainé DI, Hay DW, Rumsey WL.

J Pharmacol Exp Ther. 2013 May;345(2):260-70. doi: 10.1124/jpet.112.202051. Epub 2013 Feb 22.

PMID:
23435542
3.

Regional function-structure relationships in lungs of an elastase murine model of emphysema.

Ishii M, Emami K, Xin Y, Barulic A, Kotzer CJ, Logan GA, Chia E, MacDuffie-Woodburn JP, Zhu J, Pickup S, Kuzma N, Kadlecek S, Podolin PL, Rizi RR.

J Appl Physiol (1985). 2012 Jan;112(1):135-48. doi: 10.1152/japplphysiol.01181.2010. Epub 2011 Sep 22.

4.

Serial MRI characterization of the functional and morphological changes in mouse lung in response to cardiac remodeling following myocardial infarction.

Alsaid H, Bao W, Rambo MV, Logan GA, Figueroa DJ, Lenhard SC, Kotzer CJ, Burgert ME, Willette RN, Ferrari VA, Jucker BM.

Magn Reson Med. 2012 Jan;67(1):191-200. doi: 10.1002/mrm.22973. Epub 2011 Jun 10.

5.

A noninvasive [99mTc]DTPA SPECT/CT imaging methodology as a measure of lung permeability in a guinea pig model of COPD.

Wu Y, Kotzer CJ, Makrogiannis S, Logan GA, Haley H, Barnette MS, Sarkar SK.

Mol Imaging Biol. 2011 Oct;13(5):923-9. doi: 10.1007/s11307-010-0423-9.

PMID:
20838905
6.

Nonpeptide tachykinin receptor antagonists. III. SB 235375, a low central nervous system-penetrant, potent and selective neurokinin-3 receptor antagonist, inhibits citric acid-induced cough and airways hyper-reactivity in guinea pigs.

Hay DW, Giardina GA, Griswold DE, Underwood DC, Kotzer CJ, Bush B, Potts W, Sandhu P, Lundberg D, Foley JJ, Schmidt DB, Martin LD, Kilian D, Legos JJ, Barone FC, Luttmann MA, Grugni M, Raveglia LF, Sarau HM.

J Pharmacol Exp Ther. 2002 Jan;300(1):314-23.

PMID:
11752131
7.

SB 239063, a potent p38 MAP kinase inhibitor, reduces inflammatory cytokine production, airways eosinophil infiltration, and persistence.

Underwood DC, Osborn RR, Kotzer CJ, Adams JL, Lee JC, Webb EF, Carpenter DC, Bochnowicz S, Thomas HC, Hay DW, Griswold DE.

J Pharmacol Exp Ther. 2000 Apr;293(1):281-8.

PMID:
10734180
8.

The antitussive activity of delta-opioid receptor stimulation in guinea pigs.

Kotzer CJ, Hay DW, Dondio G, Giardina G, Petrillo P, Underwood DC.

J Pharmacol Exp Ther. 2000 Feb;292(2):803-9.

PMID:
10640321
9.

Antiasthmatic activity of the second-generation phosphodiesterase 4 (PDE4) inhibitor SB 207499 (Ariflo) in the guinea pig.

Underwood DC, Bochnowicz S, Osborn RR, Kotzer CJ, Luttmann MA, Hay DW, Gorycki PD, Christensen SB, Torphy TJ.

J Pharmacol Exp Ther. 1998 Dec;287(3):988-95.

PMID:
9864284
10.

Comparison of phosphodiesterase III, IV and dual III/IV inhibitors on bronchospasm and pulmonary eosinophil influx in guinea pigs.

Underwood DC, Kotzer CJ, Bochnowicz S, Osborn RR, Luttmann MA, Hay DW, Torphy TJ.

J Pharmacol Exp Ther. 1994 Jul;270(1):250-9.

PMID:
8035322

Supplemental Content

Loading ...
Support Center